Dr. Zarmeen Zahid
@zarmeen_z
Post-doctoral research fellow @JHPsychedelics | I study psychedelics and talk about it @PsychedBrainSci | All opinions here are my own |
WOW! What a week yall! Keep your eyes and ears open this week for @JasterAlaina as her silence can officially be broken on the DEA hearing! Hoping to drop a juicy insider look by the weekend 👩🔬
Very important research indicating no difference between psilocybin versus placebo in the treatment of (mostly severe) AUD. This research points to the importance of investigating treatment and patient-related characteristics that may inform efficacy and outcomes.
🎉NEW PAPER ALERT🎉In an RCT, we found no difference between psilocybin and placebo in alcohol use characterstics in a relapse prevention framework for AUD patients. So excited to finally share these findings! sciencedirect.com/science/articl…
A humungous finding from my incredibly talented friend and peer Dr. Rieser!!!!
🎉NEW PAPER ALERT🎉In an RCT, we found no difference between psilocybin and placebo in alcohol use characterstics in a relapse prevention framework for AUD patients. So excited to finally share these findings! sciencedirect.com/science/articl…
We’re happy to share HOPE’s (@psychedelethics) response to the PATH Caucus’s Request for Information (RFI) on psychedelics. Our response, linked below, highlights key considerations for the field. @Katherine_Chg, @CaleighPropes, @eddietalksdrugs, @briandavidearp, & @ExistWell
This clinic was started with advice from Dr. Tomislav Majić, MD a psychiatrist who founded a clinic for post psychedelic difficulties in Berlin. You can read more about it below: theguardian.com/wellness/artic…
You can read more about the clinic and the psychiatrist, Dr. Azin Elizabeth Bekhrad, MD in the link below. You can reach out to inquire about an appointment at this email address: [email protected] hopkinsmedicine.org/news/articles/…
Excited to announce a clinic for individuals experiencing difficulties following a psychedelic experience. I believe this is the first clinic of its kind in the US and is right here at @HopkinsMedicine, where we aim to learn about & address the benefits & risks of psychedelics 🧵
An important new clinic was just launched at @HopkinsMedicine. There remains much to be known about the risks of psychedelics. Hopefully this initiative will serve both the immediate needs of patients and society as a whole in learning about best practices and standards of care.
Excited to announce a clinic for individuals experiencing difficulties following a psychedelic experience. I believe this is the first clinic of its kind in the US and is right here at @HopkinsMedicine, where we aim to learn about & address the benefits & risks of psychedelics 🧵
Please continue to spread the word about this trial of psilocybin for postpartum depression.
Another trial at UAB and a few other sites. This time for post-partum depression. Please share! ppdreconnectstudy.com
Johns Hopkins Research Study about Psychedelic Experiences Among Veterans Researchers at the Johns Hopkins Center for Psychedelic & Consciousness Research (CPCR) are seeking volunteers for a ~15 minute survey study about psychedelic experiences among veterans. (Note: if you…
Back for a brief announcement that our paper on "Dissociating Artificial Intelligence from Artificial Consciousness" is finally available in full on the arxiv: arxiv.org/abs/2412.04571 Explaining why standard computers are not conscious according to IIT, not matter what they do.
Recent work by CPCR Adjunct Faculty Alan Davis, Nathan Sepeda (@n_sepeda), and colleagues on patterns of psychedelic use among United States military veterans was covered by Ohio State News. Check it out! Link to original publication: tandfonline.com/doi/full/10.10… Coverage by Ohio…
We are seeking individuals with Obsessive-Compulsive Disorder to participate in a research study looking at the effects of psilocybin, a psychoactive substance found in naturally occurring mushrooms. The study will investigate psychological effects of psilocybin, including…
We will also be posting our podcast episode on Pain Circuitry & Psychedelics featuring @RamosNeuro tomorrow morning! We had some technical difficulties but all is fixed and we’re excited to bring his research to the airwaves! #yourbrainonscience #psychedelicbrainscience
We are still recruiting for our psilocybin for early-stage Alzheimer's research study 👥 The study investigates whether psilocybin, a psychedelic substance found in some species of mushrooms, can help relieve depression in people with early Alzheimer’s disease when given in a…
Reminder that science is political whether you like it or not. Politics define how we are funded and what we are funded for. Politics define what we are able to study. Politics define who will be allowed in our labs and workplaces. Politics define with whom we can collaborate.
Are #psychedelic compounds the key to #mentalhealth treatments? Listen to our #Pharmacy Experts Webinar to hear Associate Professor Cody Wenthur (@WenthurLab) discuss early clinical trials using #psilocybin & #ketamine to treat mental health conditions. bit.ly/4fhvZpR
Reviewer 1: Interesting analysis Reviewer 3: Solid work Reviewer 2: